Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
Quick Stats
Feb 03, 202658.3
AI Score
HOLD1.33
Volume Ratio
Mar 05, 2026
Next Earnings
19
+ve Days (30d)
11
-ve Days (30d)
CTNM Stock Summary
Last updated Feb 03, 2026
CTNM is currently trading at $15.21, positioned above its 200-day moving average of $8.59, indicating a long-term uptrend. The stock has a 52-week range of $3.35 to $15.48.
Technical Analysis: The 50-day moving average stands at $11.77, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 74.041, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.284, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CTNM at 58.3/100 with a HOLD recommendation.
CTNM (Contineum Therapeutics, Inc. Class A Common Stock) Indicators
Last updated Feb 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 74.041 |
| CMF (20) | 0.284 |
| ROC (10) | 28.354 |
| ADX (14) | 31.617 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.945 |
| AROONOSC (14) | 100.0 |
| WILLAMS %R (14) | -5.637 |
| MFI (14) | 78.083 |
CTNM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CTNM Price vs Max Options Open Interest
CTNM Max Change In Options Open Interest
CTNM Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CTNM Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CTNM Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CTNM Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Contineum Therapeutics, Inc. Class A Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
CTNM Moving Averages Analysis
Contineum Therapeutics, Inc. Class A Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 03, 2026
Contineum Therapeutics, Inc. Class A Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 03, 2026
CTNM (Contineum Therapeutics, Inc. Class A Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 03, 2026
| Days | MA |
|---|---|
| 10 | 13.78 |
| 20 | 12.13 |
| 30 | 12.01 |
| 50 | 11.77 |
| 100 | 11.59 |
| 200 | 8.59 |
CTNM Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 525.3 million |
| Earnings/Share ($) | -2.25 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.0529 |
| EPS Estimate Next Year ($) | -2.1986 |
| WallStreet Target Price ($) | 20.3333 |
| Most Recent Quarter |